Tags

Type your tag names separated by a space and hit enter

Use of bisphosphonates in the management of postmenopausal osteoporosis.
Ann N Y Acad Sci. 2011 Feb; 1218:15-32.AN

Abstract

Bisphosphonates are widely used in the treatment of postmenopausal osteoporosis. They decrease the rate of bone turnover, maintain or improve structural and material properties of bone, and increase bone mineral density and thereby decrease the risk of fractures. Available potent bisphosphonates can be given to patients by different dosing regimens that range from daily oral administration to yearly intravenous infusions. Controlled studies, extending to 10 years of continuous treatment, provide information about long-term efficacy and safety and can help in the planning of long-term treatment strategies. Selection of bisphosphonates for the treatment of individuals should be based on a careful review of efficacy data, a risk profile of the bisphosphonate, and values and preferences of the patient.

Authors+Show Affiliations

Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, the Netherlands. m.v.Iken@lumc.nl

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

20946579

Citation

Papapoulos, Socrates E.. "Use of Bisphosphonates in the Management of Postmenopausal Osteoporosis." Annals of the New York Academy of Sciences, vol. 1218, 2011, pp. 15-32.
Papapoulos SE. Use of bisphosphonates in the management of postmenopausal osteoporosis. Ann N Y Acad Sci. 2011;1218:15-32.
Papapoulos, S. E. (2011). Use of bisphosphonates in the management of postmenopausal osteoporosis. Annals of the New York Academy of Sciences, 1218, 15-32. https://doi.org/10.1111/j.1749-6632.2010.05767.x
Papapoulos SE. Use of Bisphosphonates in the Management of Postmenopausal Osteoporosis. Ann N Y Acad Sci. 2011;1218:15-32. PubMed PMID: 20946579.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Use of bisphosphonates in the management of postmenopausal osteoporosis. A1 - Papapoulos,Socrates E, Y1 - 2010/09/29/ PY - 2010/10/16/entrez PY - 2010/10/16/pubmed PY - 2011/4/30/medline SP - 15 EP - 32 JF - Annals of the New York Academy of Sciences JO - Ann N Y Acad Sci VL - 1218 N2 - Bisphosphonates are widely used in the treatment of postmenopausal osteoporosis. They decrease the rate of bone turnover, maintain or improve structural and material properties of bone, and increase bone mineral density and thereby decrease the risk of fractures. Available potent bisphosphonates can be given to patients by different dosing regimens that range from daily oral administration to yearly intravenous infusions. Controlled studies, extending to 10 years of continuous treatment, provide information about long-term efficacy and safety and can help in the planning of long-term treatment strategies. Selection of bisphosphonates for the treatment of individuals should be based on a careful review of efficacy data, a risk profile of the bisphosphonate, and values and preferences of the patient. SN - 1749-6632 UR - https://www.unboundmedicine.com/medline/citation/20946579/Use_of_bisphosphonates_in_the_management_of_postmenopausal_osteoporosis_ DB - PRIME DP - Unbound Medicine ER -